Quotient BioResearch launched with acquisition of HFL for #20.25 M.

(From Chemical Business NewsBase - Press Release)

Quotient BioResearch Ltd announced its launch with the acquisition of HFL Ltd, a leading UK provider of sports forensic testing and pharmaceutical research and development services, from the Horseracing Betting Levy Board. Quotient BioResearch is a new company focused on building a group of businesses centred on high quality analytical and safety evaluation services, primarily for the global pharmaceutical and biotechnology industries. The acquisition of HFL, which delivers advanced analysis of biological and pharmaceutical compounds from a world-class facility near Cambridge, UK, marks a major step in achieving this …